CD209 and malaria: Similarly, significantly more mutant variants (-383G/G) were observed in the malaria group (46.0%) compared to the control group (22.7%) for the CD209 (snp: -383A/G; rs4804803) gene, depicting the homozygous mutant variant as a susceptibility factor for clinical malaria among children in southwestern Nigeria.